CABALETTA BIO
Startup
CABALETTA BIO
Description
Cabaletta Bio develops engineered T cell therapies designed for providing a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.
Resources
CABALETTA BIO
Address
United States
Contact
contactus@cabalettabio.com
Description
Cabaletta Bio develops engineered T cell therapies designed for providing a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.
Resources
Matchmaking
Connect with CABALETTA BIO
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways